COYA vs GD · rev $7.9M vs P/E 22, rev $52.55B
Coya Therapeutics, Inc. Common Stock (COYA) versus General Dynamics Corporation (GD) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
COYA currently screens at market cap $118.0M. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Not investment advice. Open the COYA and GD stock pages for the full models.
Not investment advice.